2022
DOI: 10.3389/fphar.2022.942168
|View full text |Cite
|
Sign up to set email alerts
|

Hyperstable EGF-like bleogen derived from cactus accelerates corneal healing in rats

Abstract: Corneal scarring reduces corneal transparency, compromises vision, and is a major cause of vision loss worldwide. Epidermal growth factor (EGF), which is the prototypic member of the EGF receptor (EGFR) agonists, is present in tears to provide repair and regeneration. Recently, we discovered bleogen pB1 in the cactus plant Pereskia bleo and showed that it is a non-canonical and hyperstable EGFR agonist with EGF-like wound healing properties for diabetic rats. Here, we apply bleogen pB1 to accelerate corneal wo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 55 publications
0
6
0
Order By: Relevance
“… Effects of redox reagents, peptide to redox reagent ratio, and peptide concentration in the organic oxidative folding reaction of bleogen pB1: (A) HPLC profiles of the organic oxidative folding of bleogen pB1 (Seq: ZCKPNGAKCTEISIPPCCSNFCLRYAGQKSGTCANR) [4d,5c,16] with or without reducing cysteamine/oxidizing cystamine. Reaction condition of organic oxidative folding: 90 % morpholine, 10 % DMSO, and S‐reduced‐peptide: cysteamine: cystamine (1 : 100 : 10, mol/mol) at 4 °C.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“… Effects of redox reagents, peptide to redox reagent ratio, and peptide concentration in the organic oxidative folding reaction of bleogen pB1: (A) HPLC profiles of the organic oxidative folding of bleogen pB1 (Seq: ZCKPNGAKCTEISIPPCCSNFCLRYAGQKSGTCANR) [4d,5c,16] with or without reducing cysteamine/oxidizing cystamine. Reaction condition of organic oxidative folding: 90 % morpholine, 10 % DMSO, and S‐reduced‐peptide: cysteamine: cystamine (1 : 100 : 10, mol/mol) at 4 °C.…”
Section: Resultsmentioning
confidence: 99%
“…Examples include venom toxins, antimicrobial peptides, and hevein‐like peptides, many of which were first isolated from medicinal plants and then chemically synthesized in our laboratory. The selected panel included seven six‐cysteine CRPs (bleogen pB1, [4d,5c,16] roseltide rT1, [4a,c] roseltide rT7, [4b] alstotide aS1, [17] linaclotide, [18] ziconotide, [19] and bovine pancreatic trypsin inhibitor (BPTI), [20] two cyclic CRPs (kalata B1 and B2, [15,21] one eight‐cysteine CRPs (lybatide 1), [22] and one ten‐cysteine CRP (EAFP1 from Eucommia antifungal peptide) [23] . Linaclotide and ziconotide are examples of FDA‐approved therapeutic CRPs, for the treatment of irritable bowel disease and chronic pain, respectively.…”
Section: Resultsmentioning
confidence: 99%
“… Rate vs percentage of various organic bases in organic the oxidative folding of bleogen pB1 and kalata B1. The rates of organic oxidative folding of (A) bleogen pB1 (Seq: 9) [4d,5c,16] or (B) kalata B1 (Seq: cyclic [GLPVCGETCVGGTCNTPGCTCSWPVCTRN]) [9a,15] were determined using binary mixtures of increasing concentrations of morpholine (pKa 8.5) or 1‐methylimidazole (pKa 7.1) in pyridine (pKa 5.2). The reaction rates in pyridine were too slow (t=>24 h) to monitor directly but could be extrapolated using 90 % pyridine and 10 % DMSO.…”
Section: Resultsmentioning
confidence: 99%
“…Guided by traditional medicines, we have identified orally-active disulfide-rich peptides or microproteins from medicinal plants. These microproteins, with 6–10 cysteine residues and a molecular weight of 2–4 kDa, are bioactives that show potential as therapeutic leads for cardiovascular diseases, stress, frailty, and other chronic and age-related diseases 16 , 17 , 29 , 39 , 66 . Previously, we identified ginsentides as a group of plant-derived peptides or microproteins found in different ginseng species 18 .…”
Section: Discussionmentioning
confidence: 99%